Transfers of Value to Healthcare Professionals

Data Disclosure

In accordance with the EFPIA Disclosure Code Bayer discloses transfers of value connected to the development and commercialization of prescription-only human pharmaceuticals to healthcare professionals and healthcare organizations.
 
The disclosed data include transfers of value in four main categories

 

CategoriesTransfer of value

Healthcare Professionals

Healthcare Organizations

Donations and grants-Whether monetary or other
Events1. Registration fees
2. Travel & accommodation
1. Sponsorship
2. Registration fees (if applicable)
3. Travel & accommodation
Service and consultancy1. Fees
2. Related expenses agreed in the contract (including, for example, travel, accommodation & registration fees)
Research and developmentFees, travel & accommodation, and other related expenses that are covered in connection with the service


We at Bayer confirm that our disclosures of transfers of value (ToVs) to HCPs and HCOs have been reported in application of the EFPIA Disclosure Code key principles.

 

Learn More About our Disclosure Methodology
 

The general rules of the EFPIA Disclosure Code apply to all member companies and all companies will disclose transfers of value made to healthcare professionals and healthcare organizations in a pre-defined format. However, some details of the reporting methodology are left for the individual companies to decide in order to allow the necessary flexibility to adjust to the internal processes. This methodology note allows you to understand how Bayer is documenting and disclosing the relevant information.

 

Go to Disclosure Methodology

 

UI web & mobile
Get Access to the Cyprus Data
202120222023
PDF-DownloadPDF-DownloadPDF-Download